Adverse events228

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 228

Type	Event	Organ system	Group	Affected	At risk	Events
other	Injection site pain	General disorders	Iltamiocel - Double-Blind Period	10	199	11
other	Injection site pain	General disorders	Placebo - Double-Blind Period	1	98	1
other	Injection site pain	General disorders	Iltamiocel - Unblinded Period	0	198	0
other	Injection site pain	General disorders	Placebo Receiving Open Label Iltamiocel in Unblinded Period	1	92	1
other	Urinary tract infection	Infections and infestations	Iltamiocel - Double-Blind Period	36	199	53
other	Urinary tract infection	Infections and infestations	Placebo - Double-Blind Period	14	98	19
other	Urinary tract infection	Infections and infestations	Iltamiocel - Unblinded Period	14	198	16
other	Urinary tract infection	Infections and infestations	Placebo Receiving Open Label Iltamiocel in Unblinded Period	10	92	12
other	Back pain	Musculoskeletal and connective tissue disorders	Iltamiocel - Double-Blind Period	7	199	8
other	Back pain	Musculoskeletal and connective tissue disorders	Placebo - Double-Blind Period	5	98	6
other	Back pain	Musculoskeletal and connective tissue disorders	Iltamiocel - Unblinded Period	2	198	2
other	Back pain	Musculoskeletal and connective tissue disorders	Placebo Receiving Open Label Iltamiocel in Unblinded Period	3	92	3
other	Dysuria	Renal and urinary disorders	Iltamiocel - Double-Blind Period	20	199	20
other	Dysuria	Renal and urinary disorders	Placebo - Double-Blind Period	7	98	8
other	Dysuria	Renal and urinary disorders	Iltamiocel - Unblinded Period	1	198	1
other	Dysuria	Renal and urinary disorders	Placebo Receiving Open Label Iltamiocel in Unblinded Period	6	92	6
other	Sinusitis	Infections and infestations	Iltamiocel - Double-Blind Period	11	199	11
other	Sinusitis	Infections and infestations	Placebo - Double-Blind Period	1	98	1
other	Sinusitis	Infections and infestations	Iltamiocel - Unblinded Period	4	198	4
other	Sinusitis	Infections and infestations	Placebo Receiving Open Label Iltamiocel in Unblinded Period	2	92	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01893138/events

API reference For AI assistants

Adverse events228

Sources 3

Read this list from software.